Related Experiment Video
Updated: Jan 15, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Determinants of left ventricular mass in children with autosomal recessive polycystic kidney disease
Mathew Lin1, Jeremy Rubin2, Robert A Palermo3,4
1Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Insights
In children with autosomal recessive polycystic kidney disease (ARPKD), left ventricular (LV) mass was not linked to blood pressure but showed a negative association with kidney function (eGFR). Young patients often have hypertension.
Area of Science:
- Pediatric Nephrology
- Cardiology
- Genetics
Background:
- Hypertension and left ventricular hypertrophy (LVH) are prevalent in children with autosomal recessive polycystic kidney disease (ARPKD).
- Understanding the determinants of left ventricular (LV) mass is crucial for managing cardiovascular risk in this population.
Purpose of the Study:
- To investigate the clinical factors associated with LV mass in pediatric patients diagnosed with ARPKD.
- To explore the relationship between blood pressure parameters, renal function, and LV mass in children with ARPKD.
Main Methods:
- Retrospective analysis of echocardiogram data from 30 children with ARPKD.
- Collected data included casual blood pressure (BP) percentiles, 24-h ambulatory BP monitoring (ABPM) parameters, antihypertensive medication use, and estimated glomerular filtration rate (eGFR).
- Outcomes assessed were LV mass Z-score, LV mass index (LVMI), and the presence of LVH.
Main Results:
- LVH was observed in 23% to 50% of patients based on different LVMI criteria.
- Younger age correlated with increased antihypertensive use and higher BP percentiles.
- LV mass was not significantly associated with casual BP or ABPM after adjusting for covariates, but showed a negative association with eGFR.
Conclusions:
- Young children with ARPKD exhibit a significant burden of hypertension.
- Left ventricular mass in pediatric ARPKD is unexpectedly not associated with blood pressure but is negatively correlated with estimated glomerular filtration rate (eGFR).
Background:
Hypertension and left ventricular (LV) hypertrophy (LVH) are common in autosomal recessive polycystic kidney disease (ARPKD). We examined clinical determinants of LV mass in children with ARPKD.
Methods:
Retrospective study of patients with ARPKD with available echocardiogram data. Casual blood pressure (BP) percentiles, 24-h ambulatory BP monitor (ABPM) parameters, antihypertensive medications, and estimated glomerular filtration rate (eGFR) within 6 months of echocardiogram were collected. Outcomes included LV mass Z-score, LV mass index [LVMI in g/m2.7 and g/(m2.16 + 0.09)], and LVH.
Results:
Thirty patients with ARPKD (median age 7.2 years [IQR 3.4, 12.8]) had echocardiograms, 28 had casual BPs, 11 had ABPMs, and 93% were on antihypertensives. LVH occurred in 23% based on LVMI in g/m2.7 > 95th percentile, and in 50% based on LVMI > 45 g/(m2.16 + 0.09). Younger age correlated with higher number of antihypertensives (ρ = - 0.46, P = 0.014) and higher casual systolic and diastolic BP percentiles (r = - 0.74, P < 0.001; r = - 0.81, P < 0.001). After adjusting for age, sex, and eGFR, LV mass was not significantly associated with casual BP or ABPM, except for a negative association between LV mass Z-score and casual diastolic BP percentile (β coefficient - 0.31, P = 0.04). After adjusting for age, sex, and casual BP, both LVMI [in g/m2.7 and g/(m2.16 + 0.09)] and LV mass Z-score were significantly negatively associated with eGFR (β -1.08, P = 0.003; β -0.79, P = 0.007; and β -0.07, P = 0.01, respectively).
Conclusions:
Young children with ARPKD have a higher burden of hypertension. LV mass was unexpectedly not significantly associated with BP but was negatively associated with eGFR.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction

